Health, Medical & Pharma News - Updated Daily page 222

Another Unwanted Gift From Climate Change: More Salmonella

Climate change will increase people s risk of salmonella poisoning from contaminated food, a new study warns. Increased humidity will make it more likely that l

Greater Alcohol Intake Tied to Higher Gout Risk

Higher consumption of alcoholic beverages is associated with a higher risk for gout among both sexes, according to a study published online Aug. 28 in JAMA Netw

Naloxone Aids Out-of-Hospital Cardiac Arrest Outcomes, Regardless of Drug Use

Regardless of drug use, administration of naloxone during out-of-hospital cardiac arrest (OHCA) is associated with improved outcomes, such as increased survival

First Cluster of Cases of Human Bird Flu Detected at Colorado Poultry Facilities

The first known U.S. cluster of cases of bird flu in humans has been recorded at two poultry facilities in Colorado, the Centers for Disease Control and Prevent

Cutting Proportion of RNs on Care Teams Tied to Worse Outcomes

the human and economic consequences of which could be substantial, the authors write.Abstract Full Text

2018 to 2021 Saw No Change in Rates of Intimate Partner Homicide Among Women

U.S. rates of intimate partner homicide involving female victims did not significantly change from 2018 to 2021, according to research published in the Aug. 29

U.S. Caregivers Face Worsening of Their Own Health Challenges

The health of U.S. caregivers is worse than that seen in adults without the responsibility of caring for someone with a health problem or disability, according

Merck Announces Phase 3 Trial Initiation for Bomedemstat, an Investigational Candidate for the Treatment of Certain Patients With Essential Thrombocythemia

Merck (NYSE MRK), known as MSD outside of the United States and Canada, today announced the initiation of Shorespan-007, a pivotal Phase 3 clinical trial evalua

Lilly Releases Zepbound (tirzepatide) Single-Dose Vials, Expanding Supply and Access for Adults Living with Obesity

Eli Lilly and Company (NYSE LLY) today announced Zepbound (tirzepatide) 2.5 mg and 5 mg single-dose vials are available for self-pay for patients with an on-lab

Astellas Initiates Phase 3 Clinical Study of Fezolinetant for VMS in Women with Breast Cancer Receiving Adjuvant Endocrine Therapy

TOKYO, Aug. 27, 2024. Astellas Pharma Inc. (today announced dosing of the first patient in the HIGHLIGHT 1 Phase 3 pivotal study for fezolinetant, an investigat

Pharmaceutical News and Articles